geneCORE Immunotherapy Panel-1
768 hours
₹70,000View detailsPDL-1 22C3 Dako
The PDL-1 22C3 Dako test is an advanced diagnostic test used to measure the expression of the PD-L1 protein on tumor cells. It helps determine whether a patient may respond well to immunotherapy drugs such as pembrolizumab (Keytruda).
DiagnosticsLab test
Know more about this test
The PDL-1 22C3 Dako test is an advanced diagnostic test used to measure the expression of the PD-L1 protein on tumor cells. It helps determine whether a patient may respond well to immunotherapy drugs such as pembrolizumab (Keytruda).
Understanding PDL-1 22C3 Dako
Programmed Death-Ligand 1 (PD-L1) is a protein found on the surface of normal and cancer cells. It plays a key role in helping cancer cells evade the immune system by binding to the PD-1 receptor on immune cells and suppressing their attack.
The PDL-1 22C3 Dako test uses immunohistochemistry (IHC) to detect and measure PD-L1 expression in tumor tissue. The Dako 22C3 pharmDx assay is an FDA-approved companion diagnostic for selecting patients who are likely to benefit from pembrolizumab (Keytruda) and other PD-1/PD...
What does PDL-1 22C3 Dako measure?
The PDL-1 22C3 Dako test is an advanced diagnostic test used to measure the expression of the PD-L1 protein on tumor cells. It helps determine whether a patient may respond well to immunotherapy drugs such as pembrolizumab (Keytruda).
Related parameters
How does home sample collection work?
Search or choose
Find the right test or package.
Select slot
Pick a convenient time.
Phlebotomist visit
A trained expert arrives home.
Safe testing
Samples move through the lab process.
Digital reports
Reports are delivered online.